Expert in Cardiogenetics & Precision Medicine
Advancing personalized care and innovative research for patients with inherited heart diseases.
Clinical Excellence
Managed over 5,000 patient cases in the fields of cardiogenetics and oncogenetics
Affiliated Institutions and Collaborations
About Dr. Mohamed El Hachmi
Dr. Mohamed El Hachmi is a Cardiogeneticist specializing in Precision Medicine, with dual PhDs from Sapienza University of Rome and Paris Cité University. His research focuses on rare inherited heart diseases, with particular expertise in Hypertrophic Cardiomyopathy (HCM), Vascular Ehlers-Danlos Syndrome (vEDS), and Cardiac Amyloidosis (ATTR).
Dual PhD
Sapienza University of Rome & Paris Cité University
Executive Board Member
European Board of Medical Genetics (EBMG)
Former Cardiogeneticist
Hôpital Européen Georges Pompidou, Paris
Research Focus Areas
Hypertrophic Cardiomyopathy
HCMLeading the GEREMY Registry for genetic profiling and precision treatment eligibility in HCM patients. Developing risk stratification models based on genetic variants.
For Patients
HCM causes the heart muscle to thicken, making it harder to pump blood. We're studying genetic factors to improve treatment options and predict who may develop symptoms.
Vascular Ehlers-Danlos Syndrome
vEDSPrincipal investigator for the ARCADE trial, demonstrating efficacy of combination therapy with irbesartan and celiprolol in reducing major vascular events by over 50%.
For Patients
vEDS is a rare genetic disorder affecting collagen that can lead to fragile blood vessels. Our research is testing medications that may help strengthen blood vessels.
Cardiac Amyloidosis
ATTRResearching TTR genetic mutations and their role in amyloid deposition in the heart. Developing novel diagnostic approaches for earlier detection.
For Patients
In cardiac amyloidosis, abnormal proteins build up in the heart. We're working on better ways to diagnose this condition earlier and develop targeted treatments.
Latest Publications
Irbesartan and celiprolol combination therapy for vascular Ehlers-Danlos syndrome
Circulation
Read more →French Hypertrophic Cardiomyopathy Genetic Registry: 5-year outcomes and risk stratification
International Journal of Cardiology
Read more →Genetic Testing Score for Arrhythmogenic Left Ventricular Cardiomyopathy
Circulation: Genomic and Precision Medicine
Read more →Seeking Collaborative Research Opportunities
Dr. El Hachmi is actively looking for research partners in multicenter studies, cohort data sharing, and genetic screening programs for inherited cardiac disorders.